Category Specific RSS

monotherapy

Encouraged by interim data, FDA approves Pharmaxis to expand its myelofibrosis treatment trials

Fresh off reporting final interim data from their Phase 2 clinical trials for PXS-5505 to treat myelofibrosis, biotech company Pharmaxis…

2 years ago

This company might have the answer for vitiligo

Winnie Harlow isn’t just a model. She’s a trailblazer, breaking barriers and crushing beauty standards as the first supermodel with…

3 years ago